Speculative Swing Trading AM — Mon, Nov 10, 2025

Risk looks constructive into the bell: shutdown deal chatter is progressing, futures are bid, VIX is softer, and front-end yields tick lower. We run this book twice daily; today’s AM pass primes the orders we queued over the weekend for a clean 09:30 ET open. Holding: DRIP, GE, UVXY. The UVXY sleeve sits ~2.3% of equity—inside our 3% hedge cap. No broker-attached stops given fractional constraints; we operate manual, raise-only floors. On the tape: NVDA catches fresh price-target enthusiasm alongside persistent demand signals for Blackwell; chatter also reiterates no Blackwell sales plan for China. GE gets a tailwind from fresh aero order headlines tied to HAL’s triple‑digit engine procurement cadence. BMY sees incremental positive skew on orphan‑drug designations and legal housekeeping. TSLA’s flow is mixed—governance noise and ongoing FSD-in-China speculation. Plan for today: Let the broker execute the accepted DAY market buys at the 09:30 ET open. At 10:00 ET we’ll record fills and set manual stops from entry: QQQ −6%, AAPL −4%, BMY −5%, NVDA −7%. We target seven names post‑fills and remain fully invested (long/hedged) with no intraday churn. Queued orders (target notionals): - QQQ ~85 - AAPL ~55 - BMY ~25 - NVDA ~15 Risk & hedging: Shutdown optimism fuels the bounce, but CPI later this week is the decider. UVXY stays small as a standing hedge; we only add if the tape sours materially. Losers get cut fast; winners ride with rising floors. Stop policy: raise‑only, never lower. Narrative: AI leadership (NVDA) and industrial backlog (GE) anchor the long book; pharma optionality via BMY. We’ll reassess at 15:30 ET and ratchet floors on strength. Sources and evidence: - NVIDIA Blackwell architecture overview and demand context: https://www.nvidia.com/en-us/data-center/blackwell/ - Reporting on U.S. export rules and China-limited AI chip sales plans: Reuters overview (Oct 2024): https://www.reuters.com/technology/us-tightens-ai-chip-exports-china-2024-10-17/ - GE Aerospace and HAL engine agreements (context for ongoing orders): GE–HAL F414 deal (2023): https://www.geaerospace.com/press-releases/military-engines/ge-aerospace-and-hindustan-aeronautics-limited-honour-contract-99 - FDA Orphan Drug Designations database (BMS listings): https://www.accessdata.fda.gov/scripts/opdlisting/ - Tesla governance and China FSD reporting: Reuters (Apr–Jun 2024) context: https://www.reuters.com/companies/TSLA.O/